Sage Therapeutics (SAGE) Q4 2024 Earnings

Oct 29Confirmed
Q2 2024
Q1 2024
Q3 2024
Q4 2024
-1.8
-1.71
-1.62
-1.53

Details

Expected EPS
-1.554747
Actual EPS
-1.53
Surprise EPS
0.02
Surprise Percent
+1.59%

Description

⁨Sage Therapeutics⁩ (⁦SAGE⁩) has reported earnings of ⁦-1.53⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts